Advertisement

Table of Contents

January 31, 2019; 133 (5)

EDITORIAL

BLOOD COMMENTARIES

REVIEW SERIES

LYMPHOID NEOPLASIA

  • Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Christian Grommes, Sarah S. Tang, Julia Wolfe, Thomas J. Kaley, Mariza Daras, Elena I. Pentsova, Anna F. Piotrowski, Jacqueline Stone, Andrew Lin, Craig P. Nolan, Malbora Manne, Paolo Codega, Carl Campos, Agnes Viale, Alissa A. Thomas, Michael F. Berger, Vaios Hatzoglou, Anne S. Reiner, Katherine S. Panageas, Lisa M. DeAngelis and Ingo K. Mellinghoff

MYELOID NEOPLASIA

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

LETTERS TO BLOOD

BLOOD WORK